medigraphic.com
SPANISH

Revista Cubana de Pediatría

ISSN 1561-3119 (Electronic)
  • Contents
  • View Archive
  • Information
    • General Information        
    • Directory
  • Publish
    • Instructions for authors        
  • medigraphic.com
    • Home
    • Journals index            
    • Register / Login
  • Mi perfil

2015, Number 4

<< Back Next >>

Rev Cubana Pediatr 2015; 87 (4)

Clinical aspects and drug treatment of the neuropathic pain

Pozo AAJ
Full text How to cite this article

Language: Spanish
References: 23
Page: 499-506
PDF size: 155.28 Kb.


Key words:

neuropathic pain, treatment of neuropathic pain, children, adolescents, tricyclic antidepressive drugs, anti-epilepsy drugs.

ABSTRACT

Neuropathic pain occurs as direct result of a lesion or a disease affecting the somatosensory system. The neuropathic pain in a child has a number of causes: traumas, complex regional pain syndrome type 1, neurological and neuromuscular diseases, chronic infections, cancer and genetic causes. Its diagnosis may be difficult in children, so the treatment is a challenge posed to physicians who specialized in the field. Tricyclic antidepressive drugs as amitryptiline and imipramine and antiepilepsy drugs are often used in the treatment of neuropathic pain in children. Acetaminophen (paracetamol), non-steroidal anti-inflammatory drugs and tramadol are also used. Every child and adolescent suspected of neuropathic pain should be clinically assessed including exhaustive anamnesis and general, regional physical examination and use of equipment, with special emphasis on the neurological examination. A normal neurological test does not exclude the presence of neuropathic pain.


REFERENCES

  1. Merskey H. Pain terms: a list with definitions and notes on usage. Recommended by the Subcommittee on Taxonomy. Pain. 1979;6:249-52.

  2. Guevara U, Covarrubias A, Hernández A. Parámetros de práctica para el manejo del dolor agudo. Cir Ciruj. 2005;73:393-404.

  3. Van Den Kerkhof E, van Dijk A. Prevalence of chronic pain disorders in children. In: Schmidt RF, Willis WD (eds). Encyclopaedia reference of pain. Heidelberg: Springer-Verlag; 2006. p. 1972-6.

  4. Narváez MA. Tratamiento del dolor en niños. Revista El Dolor. 2011;55:42-8.

  5. Merskey H, Bogduk N. Classification of chronic pain. Seattle: IASP Press; 1997.

  6. Treede RD, Jensen TS, Campbell JN, Cruccu G, Dostrovsky JD, Griffin JW, et al. Redefinition of neuropathic pain and a grading system for clinical use: consensus statement on clinical and research diagnostic criteria. Neurology. 2008;70:1630-5.

  7. Howard RF, Wiener S, Walker SM. Neuropathic pain in children. Arch Dis Child. 2014;99:84-9.

  8. Pedemonte V, Medici C, Kanopa V, González G. Síndrome doloroso regional complejo tipo 1. Análisis de una casuística infantil. Neurología [serie en Internet]. 2015 [citado 1 de julio de 2015;30(6). Disponible en: http://www.elsevier.es/esrevista- neurologia-295-articulo-sindrome-doloroso-regional-complejo-tipo- 90433900

  9. Araujo AM, Gómez M, Pascual J, Castañeda M, Pezonaga L, Borque JL. Tratamiento del dolor en el paciente oncológico. An Sist Sanit Navar. 2004;27(3):63-75.

  10. Serra J, Onaga H. Dolor neuropático. En: Alayón A, ed. Neurología en atención primaria. Madrid: Grupo Aula Médica, S.L; 2004. p. 429-39.

  11. Haanpaa M, Treede FD. Diagnosis and classification of neuropathic pain. IASP Clinical Updates. 2010;18:1-6.

  12. Vincent B, Horle B, Wood C. Valoración del dolor en el niño. EMC-Pediatría. 2009;44(2):1-7.

  13. Walker SM. Pain in children: recent advances and ongoing challenges. BJA. 2015;114(4):101-10.

  14. Martínez Salio A, Porta Etessam J, Bebel García A, García Morales I, de la Peña Mayor P, Vicente Fatela L. Fármacos antiepilépticos y dolor neuropático. Rev Neurol. 2001;32:345-50.

  15. Berde CB, Sethna NF. Analgesics for the treatment of pain in children. N Engl J Med. 2012;347:1094-103.

  16. Butkovic D, Toljan S, Mihovilovic B. Experience with gabapentin for neuropathic pain in adolescents: report of five cases. Pediatric Anesthesia. 2006;16(3):325-9.

  17. Kachko L, Ben Ami S, Lieberman A, Shor R, Tzeitlin E, Efrat R. Neuropathic pain other than CRPS in children and adolescents: incidence, referral, clinical characteristics, management, and clinical outcomes. Pediatric Anesthesia. 2014;24:608-13.

  18. Lundeberg S. Pain in children-are we accomplishing the optimal pain treatment? Pediatric Anesthesia. 2015;25(1):83-92.

  19. Rodríguez-López MJ, Fernández-Baena M, Barroso A, Yáñez-Santos JA. Complex regional pain syndrome in children: a multidisciplinary approach and invasive techniques for the management of nonresponders. Pain Practice [serie en Internet]. 2015 jun 11 [citado 18 de junio de 2015];15(5). Disponible en: http://onlinelibrary.wiley.com/enhanced/doi/10.1111/papr.12317

  20. Fernández A. Dolor oncológico. Bol Pediatr. 2000;40:215-22.

  21. Vondracek P, Oslejskova H, Kepak T, Mazanek P, Sterba J, Rysava M, et al. Efficacy of pregabalin in neuropathic pain in paediatric oncological patients. European Journal of Paediatric Neurology. 2009,13(4):332-6.

  22. Taylor M, Jakacki R, May C, Howrie D, Maurer S. Ketamine PCA for treatment of end-of-life neuropathic pain in pediatrics. Am J Hosp Palliat Care [serie en Internet]. 2014 jul 15 [citado 2 de mayo de 2015]. Disponible en: http://ajh.sagepub.com/content/early/2014/07/14/1049909114543640.long

  23. Collado AM, Odales R, Piñón A, Alerm A, González U. Relaciones interpersonales en el nuevo modelo de atención sanitarista al niño con dolor. Rev Cubana Pediatr [serie en Internet ]. 2014 jun [citado 2 de mayo de 2015];86(2). Disponible en: http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S0034- 75312014000200011&lng=es&nrm=iso&tlng=es




2020     |     www.medigraphic.com

Mi perfil

C?MO CITAR (Vancouver)

Rev Cubana Pediatr. 2015;87